186 related articles for article (PubMed ID: 22484852)
1. Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.
Ling B; Wang GX; Long G; Qiu JH; Hu ZL
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1355-61. PubMed ID: 22484852
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.
Ma H; Liu B; Wang S; Liu J
Cell Biochem Funct; 2016 Dec; 34(8):613-619. PubMed ID: 27862077
[TBL] [Abstract][Full Text] [Related]
3. miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer.
Yan X; Chen X; Liang H; Deng T; Chen W; Zhang S; Liu M; Gao X; Liu Y; Zhao C; Wang X; Wang N; Li J; Liu R; Zen K; Zhang CY; Liu B; Ba Y
Mol Cancer; 2014 Sep; 13():220. PubMed ID: 25248370
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3.
Jin Q; Zhang N; Zhan Y; Xu X; Han C; Zhao H; Hu X; Tang H; Wu Y
Technol Cancer Res Treat; 2023; 22():15330338231157156. PubMed ID: 36916303
[No Abstract] [Full Text] [Related]
8. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
9. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of miR‑205‑5p promotes apoptosis and inhibits proliferation and invasion in lung cancer A549 cells by upregulation of ZEB2 and downregulation of erbB3.
Jiang M; Zhong T; Zhang W; Xiao Z; Hu G; Zhou H; Kuang H
Mol Med Rep; 2017 May; 15(5):3231-3238. PubMed ID: 28350117
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-3196 suppresses cell proliferation and induces cell apoptosis through targeting ERBB3 in breast cancer.
Ji ZC; Han SH; Xing YF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8383-8390. PubMed ID: 30556879
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor.
Gao B; Hao S; Tian W; Jiang Y; Zhang S; Guo L; Zhao J; Zhang G; Yan J; Luo D
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 27813254
[TBL] [Abstract][Full Text] [Related]
13. Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells.
Rai K; Takigawa N; Ito S; Kashihara H; Ichihara E; Yasuda T; Shimizu K; Tanimoto M; Kiura K
Mol Cancer Ther; 2011 Sep; 10(9):1720-7. PubMed ID: 21712475
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
15. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma.
Liu T; Zhu J; Du W; Ning W; Zhang Y; Zeng Y; Liu Z; Huang JA
Respir Res; 2020 Sep; 21(1):227. PubMed ID: 32873299
[TBL] [Abstract][Full Text] [Related]
16. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
Wang XF; Shi ZM; Wang XR; Cao L; Wang YY; Zhang JX; Yin Y; Luo H; Kang CS; Liu N; Jiang T; You YP
J Cancer Res Clin Oncol; 2012 Apr; 138(4):573-84. PubMed ID: 22207524
[TBL] [Abstract][Full Text] [Related]
17. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.
Ding X; Yang Y; Sun Y; Xu W; Su B; Zhou X
Clin Transl Oncol; 2017 May; 19(5):546-552. PubMed ID: 27743168
[TBL] [Abstract][Full Text] [Related]
19. Suppression of cell growth and invasion by miR-205 in breast cancer.
Wu H; Zhu S; Mo YY
Cell Res; 2009 Apr; 19(4):439-48. PubMed ID: 19238171
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
